Anbieter: WeBuyBooks, Rossendale, LANCS, Vereinigtes Königreich
EUR 13,99
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned. Ex library copy with usual stamps & stickers.
Anbieter: Anybook.com, Lincoln, Vereinigtes Königreich
EUR 21,29
Anzahl: 1 verfügbar
In den WarenkorbZustand: Fair. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. Book contains pencil markings. In fair condition, suitable as a study copy. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,450grams, ISBN:9783540199571.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 74,00
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. 208 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 150,37
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 203 pages. 9.50x6.50x0.50 inches. In Stock.
Taschenbuch. Zustand: Neu. Evaluation of Cancer Screening | Jocelyn Chamberlain (u. a.) | Taschenbuch | xi | Englisch | 1995 | Springer | EAN 9783540199571 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Critically examining the case for and against screening people for early detection of cancer, this book reviews research-based knowledge on the value of early diagnosis for several different cancers ranging from neuroblastoma in infants to prostate cancer in old age. For each cancer site, the natural history of disease progression is reviewed and how the course may be altered by early intervention. Available screening tests are assessed both for their potential benefit and disadvantage. The information presented in this thoughtful review will assist health policy-makers to make decisions on cancer screening. Clinical researchers considering setting up screening studies will be made aware of the pitfalls of evaluation; practitioners and postgraduate students will find a readable introduction to the subject.